#Coreg medication skin#
Physical: Baseline weight, skin condition, neurologic status, P, BP, ECG, respiratory status, LFTs, renal and thyroid function tests, blood and urine glucose.History: CHF, bronchial asthma, heart block, cardiogenic shock, hypersensitivity to carvedilol, pregnancy, lactation, hepatic impairment, peripheral vascular disease, thyrotoxicosis, diabetes, anesthesia or major surgery.Patients with NYHA class IV cardiac failure, 2nd or 3rd ° AV block, sick sinus syndrome (unless a permanent pacemaker is in place), cardiogenic shock or severe bradycardia. Hypersensitivity severe chronic heart failure, bronchial asthma or related bronchospastic conditions severe hepatic impairment.Diarrhea, nausea, vomiting, insomnia, hypercholesterolemia, weight gain, abnormal vision, rhinitis, pharyngitis and hypertriglyceridemia. Bradycardia, AV block, angina pectoris, hypervolemia, leucopenia, hypotension, peripheral edema, allergy, malaise, fluid overload, melena, periodontitis, hyperuricemia, hyponatremia, increased alkaline phosphatase, glycosuria, prothrombin time, SGPT and SGOT levels, purpura, somnolence, impotence, albuminuria, hypokinesia, nervousness, sleep disorder, skin reaction, tinnitus, dry mouth, anemia, sweating, fatigue, arthralgia, aggravation, dizziness.Left ventricular dysfunction (LVD) after MI.Treatment of mild to severe CHF of ischemic or cardiomyopathic origin with digitalis, diuretics, ACE inhibitors.Hypertension, alone or with other oral drugs, especially diuretics.
Alternatively, initial dose of 6.25 mg bid increased to 12.5 mg bid after 1-2 wk, increased further if necessary to 50 mg once daily or in divided doses.
0 kommentar(er)
